Probable Function: Cell surface metalloreductase potentially involved in iron or copper homeostasis.
AIM14 (Altered Inheritance of Mitochondria protein 14) is also known as YNO1 or is encoded by the gene YGL160W in Saccharomyces cerevisiae. It functions as a NADPH oxidase ortholog and has been identified as a probable metalloreductase. The protein plays a significant role in redox processes within yeast cells, as evidenced by increased superoxide levels upon its overexpression . The full protein consists of 570 amino acids and is involved in several cellular functions related to oxidative metabolism.
Recombinant AIM14 protein is typically supplied as a lyophilized powder and should be stored at -20°C/-80°C upon receipt. For long-term storage, the following protocol is recommended:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is standard)
Aliquot to avoid repeated freeze-thaw cycles
The reconstituted protein is typically stored in a Tris/PBS-based buffer with 6% Trehalose at pH 8.0 to maintain stability .
For effective overexpression of AIM14 in yeast systems, researchers have successfully employed several expression vectors and protocols:
| Expression Vector | Promoter Type | Induction Method | Expression Level | Reference |
|---|---|---|---|---|
| pCM297 | Doxycycline-inducible | 100 mg/L doxycycline | Moderate | |
| pYES2 | GAL1 (galactose-inducible) | 3% galactose | High |
For optimal experimental design:
Select an expression system based on your experimental needs (moderate expression with tight regulation using pCM297 or high expression using pYES2)
Transform the construct into appropriate yeast strains (BY4741 has been successfully used)
Grow cultures to mid-exponential phase before induction
For doxycycline-inducible systems, measure activity at multiple time points (e.g., 6 and 16 hours post-induction)
For GAL1 promoter systems, ensure complete media change from glucose to galactose-containing media
This methodology allows for controlled expression studies to examine AIM14's function in various cellular contexts.
Given AIM14/YNO1's function as a NADPH oxidase that generates superoxide, the following assays are appropriate for measuring its activity:
Dihydroethidium (DHE) assay: This is the primary method used to detect superoxide production. When overexpressing YNO1 in the BY4741 strain, a 50% increase in DHE oxidation has been observed compared to control strains carrying empty vectors .
Growth phenotype analysis: Overexpression of YNO1 causes a significant increase in the proportion of budded cells in stationary phase, providing an indirect measure of AIM14 activity's effect on cell cycle .
Cytoskeletal visualization: Using genomic integration of ABP140-eGFP in SEY strain backgrounds, researchers can visualize effects on the actin cytoskeleton following AIM14 manipulation. This can be coupled with Latrunculin B treatment (20 μM) to assess interactions with cytoskeletal dynamics .
For quantitative assessment, fluorescence spectroscopy or microscopy techniques should be employed with appropriate controls, including the empty vector and known NADPH oxidase positive controls (such as PaNOX1).
AIM14/YNO1 functions within a complex network of redox-active proteins in yeast. Unlike other ferric/cupric reductases (FRE family proteins), AIM14 produces superoxide in a manner similar to mammalian NADPH oxidases. When investigating its interactions:
Consider potential functional overlap with FRE1, FRE3, and FRE8, which have been experimentally compared but show distinct activity profiles
Examine its role in redox-dependent cellular processes, as overexpression causes phenotypes consistent with altered redox status
Investigate physical and genetic interactions through approaches such as:
A comprehensive interaction study would provide valuable insights into AIM14's role in cellular redox homeostasis and potentially reveal novel functions beyond currently known activities.
Purification of functional recombinant AIM14 presents several challenges that researchers should address:
Membrane protein solubilization: As AIM14 contains transmembrane domains, selection of appropriate detergents is critical. Consider a screening approach with detergents like DDM, CHAPS, or Triton X-100 at varying concentrations.
Maintaining redox cofactors: Since AIM14 functions as an oxidoreductase, preserving its cofactor binding capacity is essential. Include appropriate cofactors (NADPH) in purification buffers.
Protein stability: The presence of 6% trehalose in storage buffers suggests stability issues. Monitor protein aggregation during purification using dynamic light scattering.
Activity preservation: Design activity assays that can be performed at each purification step to track retention of enzymatic function.
Expression system selection: While E. coli expression has been reported , consider yeast-based expression systems for proper post-translational modifications.
A systematic approach comparing different purification strategies should be employed, documenting yield, purity, and activity retention at each step to optimize the protocol.
Genetic interaction screens can provide valuable insights into AIM14's functional pathways. Based on methodologies applied to other yeast proteins:
Synthetic Genetic Array (SGA) analysis: Construct query strains containing either complete deletion (aim14Δ) or catalytically inactive (aim14-K318A) alleles. Cross these with:
The yeast single-gene deletion collection
Temperature-sensitive (TS) allele collection
Quantification approaches:
Validation of top hits:
Pathway analysis:
Group interacting genes by function (GO terms)
Identify enriched pathways and cellular processes
Map physical interactions to complement genetic data
This approach has successfully revealed unexpected roles for other yeast proteins, such as Hrq1's involvement in transcription regulation , and could similarly uncover novel functions for AIM14.
| Challenge | Possible Causes | Solutions |
|---|---|---|
| Low protein yield | Toxicity to expression host | Use tightly regulated promoters (e.g., doxycycline-inducible system) |
| Protein degradation | Add protease inhibitors; optimize harvesting time | |
| Loss of activity upon storage | Freeze-thaw damage | Aliquot properly; avoid repeated freeze-thaw cycles |
| Cofactor loss | Reconstitute in buffer containing relevant cofactors | |
| Inconsistent activity measurements | Variable expression levels | Normalize to protein concentration; use internal controls |
| Oxidase auto-inactivation | Perform assays immediately after induction/preparation | |
| Poor solubility | Transmembrane domains | Use appropriate detergents; consider membrane fraction preparations |
When troubleshooting experiments with AIM14, systematically analyze each step of your workflow, and document all conditions and variations to identify optimal parameters for your specific experimental system.
Distinguishing between direct and indirect effects of AIM14 in oxidative stress requires thoughtful experimental design:
Use catalytically inactive mutants: Compare phenotypes between aim14Δ and catalytically inactive mutants (e.g., aim14-K318A) to distinguish between enzymatic and structural functions .
Temporal analysis: Monitor superoxide production immediately following induction using time-course experiments with DHE assays.
Compartment-specific measurements: Use organelle-targeted oxidative stress sensors to determine where ROS accumulation occurs first.
Transcriptional profiling:
Compare gene expression changes between wild-type and aim14 mutants
Focus on genes known to respond to oxidative stress
Look for patterns consistent with direct vs. indirect responses
Biochemical validation:
Perform in vitro assays with purified components
Test direct oxidation of putative targets
Use separation techniques to identify direct binding partners
Genetic epistasis analysis:
Create double mutants with other oxidative stress pathway components
Determine whether phenotypes are additive or epistatic
By combining these approaches, researchers can build a comprehensive model distinguishing primary from secondary effects of AIM14 activity.
For rigorous analysis of AIM14 functional studies, consider the following statistical approaches:
For DHE assay data:
Normalize fluorescence readings to cell density
Use paired t-tests or ANOVA with post-hoc tests for comparing multiple conditions
Present data as fold-change relative to control with standard deviation
For growth phenotype analysis:
Apply area under curve (AUC) calculations for growth curves
Use non-parametric tests if data doesn't meet normality assumptions
Consider repeated measures ANOVA for time-course experiments
For genetic interaction screens:
Calculate SGA scores that quantify the deviation of observed growth from expected growth
Apply appropriate cutoffs (typically ±2-3 standard deviations from mean) to identify significant interactions
Perform false discovery rate (FDR) correction for multiple hypothesis testing
For transcriptomic data:
Use differential expression analysis tools (DESeq2, edgeR)
Apply gene set enrichment analysis (GSEA) to identify affected pathways
Validate key findings with RT-qPCR
Replication requirements:
Perform at least three biological replicates
Include technical replicates to assess measurement variation
Report both p-values and effect sizes when presenting results
Based on current knowledge and analogies to similar proteins, several promising research directions for AIM14 include:
Cell cycle regulation: The observation that YNO1 overexpression increases budded cells in stationary phase suggests a potential role in cell cycle control. Investigating interactions with cell cycle checkpoints could reveal novel regulatory mechanisms .
Stress response pathways: Beyond oxidative stress, AIM14 may function in other stress response pathways. Systematic testing of aim14 mutants under various stress conditions (osmotic, temperature, pH) could uncover additional functions.
Metabolic regulation: As a redox-active enzyme, AIM14 likely influences metabolic pathways. Metabolomics approaches comparing wild-type and mutant strains could reveal affected pathways.
Protein quality control: Recent studies with other yeast proteins have revealed unexpected connections to protein quality control systems. AIM14 might play a role in redox-dependent protein folding or degradation.
Transcriptional regulation: Similar to findings with the Hrq1 helicase in yeast , AIM14 might influence gene expression patterns. RNA-seq analysis of aim14 mutants could reveal transcriptional effects.
Integrative approaches combining multiple omics technologies would be particularly powerful for mapping these potential new functions of AIM14.
Comparative analyses between AIM14/YNO1 and mammalian NADPH oxidases (NOX family) would significantly advance our understanding of these enzymes:
Structural comparisons:
Align conserved domains and catalytic sites
Model substrate binding pockets
Compare transmembrane topology and membrane association
Functional complementation experiments:
Express mammalian NOX proteins in aim14Δ yeast
Test if human NOX can rescue yeast phenotypes
Express AIM14 in mammalian cell lines with NOX knockdowns
Regulatory mechanism comparison:
Identify conserved regulatory subunits or interacting partners
Compare activation stimuli across species
Analyze post-translational modification sites
Inhibitor cross-reactivity studies:
Test whether known NOX inhibitors affect AIM14 activity
Develop parallel screening approaches for inhibitor discovery
Use mutational analysis to validate conserved inhibitor binding sites
This comparative approach could identify fundamental mechanisms conserved across evolution while highlighting species-specific adaptations in redox regulation.